172 related articles for article (PubMed ID: 36302162)
1. Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.
Casey JL; Dore GJ; Grebely J; Matthews GV; Cherepanov V; Martinello M; Marks P; Janssen HLA; Hansen BE; Kaul R; MacParland SA; Gehring AJ; Feld JJ
J Viral Hepat; 2023 Jan; 30(1):64-72. PubMed ID: 36302162
[TBL] [Abstract][Full Text] [Related]
2. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
Kuriry H; Casey J; Krassenburg L; La D; Kuczynski M; Shah H; Janssen HLA; Hansen BE; Feld JJ
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2398-2406.e1. PubMed ID: 32629131
[TBL] [Abstract][Full Text] [Related]
4. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
5. Effect of Direct Acting Antivirals (DAAs) on Myeloid-Derived Suppressor Cells Population in Egyptian Chronic Hepatitis C Virus Patients: A Potential Immunomodulatory Role of DAAs.
Abdulsamad B; Afifi M; Awaad AK; Elbendary W; Mustafa H; Elsherbini B
Viral Immunol; 2023 May; 36(4):259-267. PubMed ID: 36802279
[TBL] [Abstract][Full Text] [Related]
6. IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses.
Han JW; Sung PS; Hong SH; Lee H; Koh JY; Lee H; White S; Maslow JN; Weiner DB; Park SH; Jeong M; Heo J; Ahn SH; Shin EC
J Hepatol; 2020 Jul; 73(1):72-83. PubMed ID: 32088322
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA;
J Gastroenterol Hepatol; 2013 Nov; 28(11):1770-81. PubMed ID: 23663030
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
[TBL] [Abstract][Full Text] [Related]
9. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.
Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T
J Viral Hepat; 2022 May; 29(5):385-394. PubMed ID: 35274399
[TBL] [Abstract][Full Text] [Related]
10. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment.
Romano C; Tortorella O; Dalla Mora L; Di Stasio D; Sellitto A; Adinolfi LE; Marrone A
Front Immunol; 2022; 13():882064. PubMed ID: 35479086
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
[TBL] [Abstract][Full Text] [Related]
13. Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.
Tanaka T; Voigt MD
J Hepatobiliary Pancreat Sci; 2019 Sep; 26(9):393-400. PubMed ID: 31211912
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Kakuda Y; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
Cancer Med; 2022 Apr; 11(8):1769-1786. PubMed ID: 35174643
[TBL] [Abstract][Full Text] [Related]
15. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
16. Acute hepatitis C virus infection: clinical update and remaining challenges.
Liu CH; Kao JH
Clin Mol Hepatol; 2023 Jul; 29(3):623-642. PubMed ID: 36800699
[TBL] [Abstract][Full Text] [Related]
17. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.
Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ohara M; Izumi T; Umemura M; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
J Viral Hepat; 2017 Dec; 24(12):1098-1106. PubMed ID: 28632923
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity.
Mondelli MU; Ottolini S; Oliviero B; Mantovani S; Cerino A; Mele D; Varchetta S
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203436
[TBL] [Abstract][Full Text] [Related]
19. Reversal of T Cell Exhaustion in Chronic HCV Infection.
Osuch S; Metzner KJ; Caraballo Cortés K
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722372
[TBL] [Abstract][Full Text] [Related]
20. T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Callendret B; Eccleston HB; Hall S; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2014 Nov; 60(5):1531-40. PubMed ID: 24975498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
